Main > RHEUMATOLOGY > UK. A. SLE>Treat.>Type 1 IFN Recept

---

or MAb

UK. A. SLE>Treat.>Type 1 IFN Recept's subsections
(*) USA Approval Date: 2021. 08.02
Company
Generic Name: anifrolumab
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 12
Patent>UpDate: 2021. 08.03
PR Web-Site

UK. A. SLE>Treat.>Type 1 IFN Recept's products
This section has no products